Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes

American Journal of Veterinary Research

Volumn 59, Issue 12, 1998, Pages 1568-1574

  Reagan, William J ^a,b   Scott Moncrieff, Catharine ^a   Christian, John ^a   Snyder, Paul ^a   Kelly, Kathy ^a   Glickman, Larry ^a  

^a PURDUE UNIVERSITY   (United States)

^b HESKA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G;

ANIMAL CELL; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE; CONTROLLED STUDY; DOG; DRUG BINDING; ERYTHROCYTE; FLOW CYTOMETRY; HELPER CELL; IMMUNOFLUORESCENCE TEST; LYMPHOCYTE; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; B-LYMPHOCYTES; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DOGS; ERYTHROCYTES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; LYMPHOCYTES; MONOCYTES; PHAGOCYTOSIS;

EID: 0032445458     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Schwartz SA. Intravenous immunoglobulin (IVIG) for therapy of autoimmune disorders. J Clin Immunol 1990;10:81-89 .
2. Todd AA, Yap PL. Applications of intravenous immunoglobulin in haematology. Blood Rev 1992;6:105-117.
3. Bussel JB, Cunningham-Rundles C, Abraham C Intravenous treatment of autoimmune hemolytic anemia with very high doses of gamma globulin. Vox Sang 1987;51:264-271.
4. Besa EC. Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. Am J Med 1988;84:691-698.
5. Flores G, Cunningham-Rundles C, Newland AC, et al. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol 1993;44:237-242.
6. Kimberly RP, Salmon JE, Bussel JE, et al. Modulation of mononuclear phagocyte function by intravenous gamma-globulin. J Immunol 1984;132:745-750.
7. Kelton J, Singer J, Rodger C, et al. The concentration of IgG in the serum is a major determinant of Fc-dependent reticuloendothelial function. Blood 1985;66:490-495.
8. Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 1982;306:1254-1258.
9. Ochs HD, Morell A, Skvaril F, et al. Survival of IgG subclasses following administration of intravenous gammaglobulin in patients with primary immunodeficiency diseases. In: Marcell A, Nydegger UE, eds. Clinical use of intravenous immunoglobulins. London: Academic Press Inc. 1986;77-85.
10. Pirofsky B. Safety and toxicity of a new serum immunoglobulin G intravenous preparation, IVIG pH 4.25. Rev Infect Dis 1986;8 (Suppl 4):S457-463.
11. Bussel J, Pahwa S, Porges A, et al. Correlation of in vitro antibody synthesis with the outcome of intravenous gamma-globulin treatment of chronic idiopathic thrombocytopenic purpura. J Clin Immunol 1986;6:50-56.
12. Kaveri S, Dietrich G, Hurez V, et al. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases. Clin Exp Immunol 1991;86:192-198.
13. Horneff G, Guse AH, Schulze-Koops H, et al. Human CD4 modulation in vivo induced by antibody treatment. Clin Immunol Immunopathol 1993;66:80-90
14. Stohl W. Cellular mechanisms in the in vitro inhibition of pokeweed mitogen-induced B cell differentiation by immunoglobulin for intravenous use. J Immunol 1986;136:4407-4413.
15. Stohl W. Modulation of the immune response by immunoglobulin for intravenous use. 1. Inhibition of pokeweed mitogen-induced B cell differentiation. Clin Exp Immunol 1985;62:200-207.
16. Kondo N, Kasahara K, Kameyama T, et al. Intravenous immunoglobulins suppress immunoglobulin productions by suppressing Ca(2+)-dependent signal transduction through Fc gamma receptors in B lymphocytes Scand J Immunol 1994;40:37-42.
17. Leung DYM, Burns JC, Newburger JW, et al. Reversal of lymphocyte activation in vivo in the kawasaki syndrome by intravenous gammaglobulin. J Clin Invest 1987;79:468-472.
18. Macey MG, Newland AC, Modulation of T and B cell sub-populations during high dose intravenous immunoglobulin therapy. Plasma Ther Transfus Technol 1988;9:139-147.
19. Macey MG, Newland AC. CD4 and CD8 subpopulation changes during high dose intravenous immunoglobulin treatment. Br J Haematol 1990;76:513-520.
20. Scott-Moncrieff JCR, Reagan WJ, Glickman LT, et al. Treatment of nonregenerative anemia with human gamma-globulin in dogs. J Am Vet Med Assoc 1995;206:1895-1900.
21. Scott-Moncrieff JCR, Reagan WJ, Snyder PW, et al. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia. J Am Vet Med Assoc 1997;210: 1623-1627.
22. Wunderli PS, Felsburg PJ. An improved method for isolation of enriched canine peripheral blood mononuclear cell and peripheral blood lymphocyte preparations. Vet Immunol Immunopathol 1989;20: 335-344.
23. Gebhard DH, Carter PB. Identification of canine T-lymphocyte subsets with monoclonal antibodies. Vet Immunol Immunopathol 1992;33:187-199.
24. Ruslander DA, Gehard DH, Tompkins MB, et al. lmmunophenotypic characterization of canine lymphoproliferative disorders. In Vivo 1997;11:169-172.
25. Turrini F, Arese P, Yuan J, et al Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J Biol Chem 1991;266:23611-23617.
26. Hughes P, Toogood A. Plasma exchange as a necessary prerequisite for the induction of remission by human immunoglobulin in auto-immune haemolytic anaemia. Acta Haematol 1994;91:166-169.
27. Blanchette VS, Kirby MA, Turner C. Role of intravenous immunoglobulin-G in autoimmune hematologic disorders. Semin Hematol 1992;29:72-82.
28. Björkholm M. Intravenous immunoglobulin treatment in cytopenic haematological disorders. J Intern Med 1993;234: 119-126.
29. Berkman SA, Lee ML, Gale RP. Clinical uses of intravenous immunoglobulins. Ann Intern Med 1990;112:278-292.
30. Jungi TW, Brcic M, Kuhnert P, et al. Effect of IgG for intravenous use on Fc receptor-mediated phagocytosis by human monocytes. Clin Exp Immunol 1990;82:163-169.
31. Lewis SM. Haematology of man. In: Archer RK, Jeffcott LB, eds. Comparative clinical haematology. Oxford, England: Blackwell Scientific Publications, 1977;27-102.
32. Spurling NW. Haematology of the dog. In: Archer RK, Jeffcott LB, eds. Comparative clinical haematology. Oxford, England: Blackwell Scientific Publications, 1977;365-440.
33. Klag AR, Giger U, Shofer FS. Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990). J Am Vet Med Assoc 1993;202:783-788.
34. Jackson ML, Kruth SA. Immune-mediated hemolytic anemia and thrombocytopenia in the dog: a retrospective study of 55 cases diagnosed from 1969 through 1983 at the Western College of Veterinary Medicine. Can Vet J 1985;26:245-250.
35. McGuire WA, Yang HH, Bruno E, et al. Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin. N Engl J Med 1987;317:1004-1008.
36. Nydegger UE, Sultan Y, Kazatchkine MD. The concept of anti-idiotypic regulation of selected autoimmune diseases by intravenous immunoglobulin. Clin Immunol Immunopathol 1989;53: 72-82.